We are pleased to announce that the U.S. Patent and Trademark Office has issued four patents for ClearUP that include several features to improve effectiveness and ease-of-use for consumers.
“These foundational patents protect aspects of ClearUP that make the device clinically efficacious, comfortable, and easy to use, all of which are core to its utility”, said Dr. Blake Gurfein, Chief Scientific Officer of Tivic Health. “As a member of the team who has worked carefully on the intellectual property strategy and execution, it is gratifying to receive our first set of issued patents from the US Patent and Trademark Office and look forward to several more issuances in the coming year”.
The four patents issued for ClearUP address device specifications, performance, and comfort features during treatment and future product developments. They are as follows:
- Sinus Treatment Device with Adaptive Circuit, US 10625076
- Sinus Treatment Device with Enhanced Tip, US 10596374
- Adaptive Trigger for a Microcurrent Stimulation Device, US 10537738
- Treatment Device including Wireless Interface and User Application, US 10576280
Tivic Health has an additional 14 patents pending in the U.S. and abroad.
